Table 2.
SF-36 — parameters | Values in research group | p-value | |||||
---|---|---|---|---|---|---|---|
Day 0 (before treatment) | 30 days | 90 days | 180 days | 0–30 days | 0–90 days | 0–180 days | |
Physical Functioning (median; Q1, Q3) | 5 (0; 35) | 48 (5; 70) | 68 (29; 95) | 75(45;95) | < 0.001* | < 0.001* | < 0.001* |
Limitations to the physical role | 0 (0; 50) | 0 (0; 0) | 25 (0; 100) | 75 (0; 100) | 0.07* | 0.23 | < 0.001* |
Bodily Pain | 41 (22; 100) | 57 (41; 84) | 74 (42; 100) | 84 (63;100) | 0.1 | < 0.001* | < 0.001* |
General Health perceptions | 52 (40; 65) | 56 (41; 67) | 61 (45; 76) | 76 (50;96) | 0.046* | 0.015* | 0.03* |
Vitality | 35 (25; 55) | 43 (26; 55) | 50 (30; 70) | 55 (40; 75) | 0.28 | < 0.01* | < 0.001* |
Social Functioning | 50 (37; 87) | 50 (37; 75) | 75 (37; 100) | 87 (56;100) | 0.18 | 0.1 | < 0.001* |
Emotional role limitations | 33 (0; 100) | 33 (0; 100) | 83 (0; 100) | 100(33;100) | 0.24 | 0.22 | 0.019* |
Mental Health | 56 (43; 68) | 60 (44; 76) | 66 (44; 84) | 72 (60; 82) | 0.16 | 0.026* | < 0.001* |
Synthetic index linked to physical health | 29 (23; 35) | 34 (27; 42) | 43 (32; 51) | 46 (36; 52) | < 0.001* | < 0.001* | < 0.001* |
Synthetic index linked to mental health | 44 (34; 53) | 40 (32; 51) | 43 (36; 53) | 71 (64; 100) | 0.12 | 0.18 | 0.049* |
*p-value < 0.05 was considered significant (Wilcoxon–Mann–Whitney test)